Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant | MicrobiomeTrials← Back to trialsNCT03622788
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2019-08-08Est. Completion: 2027-12-01
Enrollment target: 16 participants Locations- M D Anderson Cancer Center, Houston, Texas, United States
Other microbiome trials you might be interested in
Down SyndromeRecurrent B Acute Lymphoblastic Leukemia
This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in t…
Birmingham, United StatesEst. completion Jun 30, 2028
B-ALLHematologic MalignancySolid Tumor
This study is being done to learn more about the short-term and long-term side effects of CAR-T cell therapy. Specifical…
Philadelphia, United StatesEst. completion Mar 2027
Acute Lymphoblastic Leukemia
The aim of this study was to collect existing information from the medical charts of patients enrolled in the ongoing as…
Boston, United StatesCompleted Sep 17, 2025